New approach to celiac testing identifies more Australians at risk
Australian researchers have developed a new approach to detecting coeliac disease, revealing this immune disorder is far more common than previously recognised.
Aug 27, 2013
0
0
Australian researchers have developed a new approach to detecting coeliac disease, revealing this immune disorder is far more common than previously recognised.
Aug 27, 2013
0
0
Maternal prepregnancy obesity is associated with an elevated risk for severe maternal morbidity and/or mortality, according to a study published online June 28 in JAMA Network Open.
Jul 8, 2022
0
2
An antibody that targets and is taken up only by certain types of cancer cells has been developed by A*STAR researchers. Combining this antibody with an anticancer drug could lead to a new treatment for some types of breast ...
Jan 15, 2019
0
13
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...
Oct 1, 2012
0
0
Scientists at the Francis Crick Institute have found a new treatment target for CDKL5 deficiency disorder (CDD), one of the most common types of genetic epilepsy.
Feb 7, 2024
0
77
A team of researchers at the Carl Gustav Carus Faculty of Medicine, University of Technology Dresden, led by Prof. Frank Buchholz, has achieved a major breakthrough in genome editing technology. They've developed a cutting-edge ...
Jan 31, 2024
0
51
A form of blood cancer known as mantle cell lymphoma is critically dependent on a protein that coordinates gene expression, such that blocking its activity with an experimental drug dramatically slows the growth of this lymphoma ...
Nov 22, 2022
0
26
An anti-inflammatory drug commonly used to treat gout could significantly improve outcomes in patients with mild-to-moderate COVID-19 infections, according to research by a team led by University of Georgia professor Ralph ...
Jul 27, 2023
0
38
Medical industry sponsorship of economic evaluations on new treatments are more likely to be found 'cost-effective' than independent research across a range of diseases,
Jun 22, 2022
0
2
Professor John Whitelock is improving the smarts of antibodies and sending them into the extracellular area to outwit those clever cancer cells.
Oct 1, 2019
0
4